College males' behaviors, intentions, and influencing factors related to vaccinating against HPV.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
03 04 2021
Historique:
pubmed: 16 10 2020
medline: 6 7 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

In the US, individuals between ages 18 and 26 have the highest incidence of new human papillomavirus (HPV) infections, the most common sexually transmitted infection worldwide. HPV infection can cause genital warts, and persistent infection with cancerous strains can develop into multiple types of cancers. In 2011, the Centers for Disease Control and Prevention recommended that both men and women receive the vaccine. However, young adult men, including college-aged men, have been slow to initiate and complete the vaccine series. Our cross-sectional study, guided by the Theory of Planned Behavior, explores college men's vaccination uptake and series completion behaviors and their intentions to vaccinate. Using logistic regression, we examined how students' attitudes, perceived behavioral control, and subjective norms impacted their HPV vaccine-related behaviors and intentions. Subjective norms, followed by perceived behavioral control to communicate with a provider about the HPV vaccine, had the largest impact on students' HPV vaccine uptake and completion behaviors and intentions to vaccinate. Both subjective norms and positive attitudes about the vaccine impacted students' intentions to vaccinate against HPV. Based on these findings, we make various recommendations including campus interventions and policies that could increase HPV vaccine uptake and completion behaviors among college men.

Identifiants

pubmed: 33054675
doi: 10.1080/21645515.2020.1819101
pmc: PMC8018407
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1044-1051

Références

J Sex Med. 2013 Oct;10(10):2455-64
pubmed: 23745833
Vaccine. 2015 Aug 7;33(33):4081-6
pubmed: 26143612
J Mens Health. 2011 Oct 1;8(3):175-184
pubmed: 21966351
Prev Med. 2016 May;86:92-8
pubmed: 26868093
MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705-8
pubmed: 22189893
J Am Coll Health. 2014;62(3):186-92
pubmed: 24328855
J Behav Med. 2010 Aug;33(4):274-81
pubmed: 20162346
Ann Behav Med. 2012 Oct;44(2):171-80
pubmed: 22547155
J Community Health. 2020 Dec;45(6):1187-1195
pubmed: 32418009
Enferm Infecc Microbiol Clin. 2019 May;37(5):324-334
pubmed: 30853139
Sex Transm Dis. 2013 Mar;40(3):187-93
pubmed: 23403598
J Am Coll Health. 2016 Oct;64(7):545-54
pubmed: 27223873
J Community Health. 2017 Dec;42(6):1127-1132
pubmed: 28432549
Papillomavirus Res. 2017 Jun;3:142-148
pubmed: 28720448
Res Nurs Health. 2001 Dec;24(6):518-29
pubmed: 11746080
JAMA. 2020 Feb 4;323(5):468-469
pubmed: 31930397
Sex Transm Infect. 2013 Nov;89(7):568-74
pubmed: 23828943
J Natl Cancer Inst. 2015 Apr 29;107(6):djv086
pubmed: 25925419
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408
pubmed: 27977643
Hum Vaccin Immunother. 2019;15(7-8):1760-1766
pubmed: 31166148
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
pubmed: 17380109
NCHS Data Brief. 2020 Jan;(354):1-8
pubmed: 32487295
Am J Mens Health. 2019 Nov-Dec;13(6):1557988319883776
pubmed: 31787066
J Am Coll Health. 2017 Apr;65(3):197-207
pubmed: 27960609
Clin Infect Dis. 2019 Aug 30;69(6):1011-1018
pubmed: 30475987
Br J Soc Psychol. 2008 Dec;47(Pt 4):589-606
pubmed: 18039428
Am J Public Health. 2013 Aug;103(8):1419-27
pubmed: 23763402
Prev Med. 2007 Aug-Sep;45(2-3):107-14
pubmed: 17628649
Hum Vaccin Immunother. 2019;15(7-8):1784-1793
pubmed: 30779687
J Am Coll Health. 2012;60(1):8-12
pubmed: 22171724
Vaccine. 2018 May 3;36(19):2545-2558
pubmed: 29625768
Vaccine. 2018 Jan 4;36(2):331-341
pubmed: 28755837
Sex Transm Dis. 2010 Mar;37(3):197-203
pubmed: 20118831
Sex Transm Infect. 2016 Mar;92(2):104-7
pubmed: 26297720
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):363-72
pubmed: 19190161
Hum Vaccin Immunother. 2016 Jun 2;12(6):1454-68
pubmed: 26838681
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):724-728
pubmed: 31437140
J Community Health. 2018 Jun;43(3):459-466
pubmed: 29470802
Prev Med. 2013 Jan;56(1):35-40
pubmed: 23142106
Health Aff (Millwood). 2018 Oct;37(10):1587-1595
pubmed: 30273036

Auteurs

Alexis Koskan (A)

Arizona State University, College of Health Solutions, Phoenix, AZ, USA.

Chad Stecher (C)

Arizona State University, College of Health Solutions, Phoenix, AZ, USA.

Deborah Helitzer (D)

Arizona State University, College of Health Solutions, Phoenix, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH